Poulsen H E, Ranek L, Andreasen P B
Scand J Clin Lab Invest. 1981 Oct;41(6):573-6. doi: 10.3109/00365518109090500.
We measured the total glutathione content in 38 liver biopsies from patients undergoing diagnostic liver biopsy to study whether liver diseases result in decreased glutathione content making the liver more sensitive to different toxic damages. The glutathione concentrations ranged from 20.2 to 41.0 mumol/g hepatic protein in six biopsies without light microscopic pathological changes (mean +/- SD = 26.9 = +/- 8.1). The mean concentrations +/- SD in patients with toxic hepatitis (n = 3), viral hepatitis (n = 4), chronic active hepatitis (n = 4), cirrhosis (n = 14) and steatosis (n = 7) were 62.5 +/- 27.2, 47.4 +/- 25.9, 38.3 +/- 17.0, 29.1 +/- 15.7 and 21.0 +/- 9.6, respectively. The hepatic glutathione content is not decreased in patients with moderate hepatic impairment.
我们检测了38例接受诊断性肝活检患者的肝组织活检样本中的总谷胱甘肽含量,以研究肝脏疾病是否会导致谷胱甘肽含量降低,从而使肝脏对不同的毒性损伤更敏感。在6例无光学显微镜病理变化的活检样本中,谷胱甘肽浓度范围为20.2至41.0 μmol/g肝蛋白(平均值±标准差=26.9±8.1)。中毒性肝炎患者(n = 3)、病毒性肝炎患者(n = 4)、慢性活动性肝炎患者(n = 4)、肝硬化患者(n = 14)和脂肪变性患者(n = 7)的平均浓度±标准差分别为62.5±27.2、47.4±25.9、38.3±17.0、29.1±15.7和21.0±9.6。中度肝功能损害患者的肝脏谷胱甘肽含量并未降低。